Market Overview

Monday's #PreMarket Movers: Spectrum Pharmaceuticals, Cyberark Software Trending Down

Share:

Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) -26% - Received unfavorable litigation ruling in Fusilev case.

Cyberark Software Ltd (NASDAQ: CYBR) -5% - Downgraded to Underweight at JP Morgan.

Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) +45% - Reported research collaboration with Bristol-Myers Squibb.

Biocept Inc (NASDAQ: BIOC) +27% - Announced favorable findings from OncoCEE-BR Study.

Ballard Power Systems Inc. (USA) (NASDAQ: BLDP) +16% - Signed two new technology contracts.

Polypore International, Inc. (NYSE: PPO) +13% - Polypore’s media business will be acquired by 3M for $1 billion.

Celldex Therapeutics, Inc. (NASDAQ: CLDX) +14.5% - Received breakthrough designation from FDA for its Rintega therapy.

ADMA Biologics Inc (NASDAQ: ADMA) +5% - Reported positive data from phase III RI-002 trial.

Home Loan Servicing Solutions Ltd (NASDAQ: HLSS) +8% - New Residential will acquire HLSS for $18.25 per share.

Tower Semiconductor Ltd. (USA) (NASDAQ: TSEM) +8.7% - Announced Q4 EPS.

Valeant Pharmaceuticals Intl Inc (NYSE: VRX) +9% - Announced purchase of Salix Pharmaceuticals for ~$10 billion.

Ocwen Financial Corp (NYSE: OCN) +2.6% - Announced intent to sell $9.8 billion in assets.

Pacific Drilling SA (NYSE: PACD) +4.3% - Reported Q4 EPS.

 

Related Articles (SPPI + CYBR)

View Comments and Join the Discussion!

Posted-In: News Pre-Market Outlook Movers

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com